Literature DB >> 19581453

Inhibition of intracellular growth of Salmonella enterica serovar Typhimurium in tissue culture by antisense peptide-phosphorodiamidate morpholino oligomer.

Georgi M Mitev1, Brett L Mellbye, Patrick L Iversen, Bruce L Geller.   

Abstract

Two types of phosphorodiamidate morpholino oligomers (PMOs) were tested for inhibition of growth of Salmonella enterica serovar Typhimurium. Both PMOs have the same 11-base sequence that is antisense to the region near the start codon of acpP, which is essential for lipid biosynthesis and viability. To the 3' end of each is attached the membrane-penetrating peptide (RXR)4XB (R, X, and B indicate arginine, 6-aminohexanoic acid, and beta-alanine, respectively). One peptide-PMO (AcpP PPMO) has no charge on the PMO moiety. The second PPMO has three cations (piperazine) attached to the phosphorodiamidate linkages (3+Pip-AcpP PPMO). A scrambled-sequence PPMO (Scr PPMO) was synthesized for each type of PMO. The MICs of AcpP PPMO, 3+Pip-AcpP PPMO, and either one of the Scr PPMOs were 1.25 microM (7 microg/ml), 0.156 microM (0.94 microg/ml), and >160 microM (>900 microg/ml), respectively. 3+Pip-AcpP PPMO at 1.25 or 2.5 microM significantly reduced the growth rates of pure cultures, whereas AcpP PPMO or either Scr PPMO had no effect. However, the viable cell count was significantly reduced at either concentration of 3+Pip-AcpP PPMO or AcpP PPMO, but not with either Scr PPMO. In other experiments, macrophages were infected intracellularly with S. enterica and treated with 3 microM 3+Pip-AcpP PPMO. Intracellular bacteria were reduced >99% with 3+Pip-AcpP PPMO, whereas intracellular bacteria increased 3 orders of magnitude in untreated or Scr PPMO-treated cultures. We conclude that either AcpP PPMO or 3+Pip-AcpP PPMO inhibited growth of S. enterica in pure culture and that 3+Pip-AcpP PPMO reduced intracellular viability of S. enterica in macrophages.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19581453      PMCID: PMC2737864          DOI: 10.1128/AAC.00099-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

1.  Inhibition of Mycobacterium smegmatis gene expression and growth using antisense peptide nucleic acids.

Authors:  Agné Kulyté; Natalia Nekhotiaeva; Satish Kumar Awasthi; Liam Good
Journal:  J Mol Microbiol Biotechnol       Date:  2005

2.  Characterisation of cell-penetrating peptide-mediated peptide delivery.

Authors:  Simon W Jones; Richard Christison; Ken Bundell; Catherine J Voyce; Sarah M V Brockbank; Peter Newham; Mark A Lindsay
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

3.  Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.

Authors:  Lucas D Tilley; Orion S Hine; Jill A Kellogg; Jed N Hassinger; Dwight D Weller; Patrick L Iversen; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

4.  Distribution of prophages and SGI-1 antibiotic-resistance genes among different Salmonella enterica serovar Typhimurium isolates.

Authors:  Armand P H M Hermans; Annelien M Beuling; Angela H A M van Hoek; Henk J M Aarts; Tjakko Abee; Marcel H Zwietering
Journal:  Microbiology       Date:  2006-07       Impact factor: 2.777

Review 5.  Antibacterial antisense.

Authors:  Bruce L Geller
Journal:  Curr Opin Mol Ther       Date:  2005-04

6.  Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors.

Authors:  Jean Philippe Richard; Kamran Melikov; Hilary Brooks; Paul Prevot; Bernard Lebleu; Leonid V Chernomordik
Journal:  J Biol Chem       Date:  2005-02-01       Impact factor: 5.157

7.  Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.

Authors:  Bruce L Geller; Jesse Deere; Lucas Tilley; Patrick L Iversen
Journal:  J Antimicrob Chemother       Date:  2005-05-04       Impact factor: 5.790

8.  Bactericidal antisense effects of peptide-PNA conjugates.

Authors:  L Good; S K Awasthi; R Dryselius; O Larsson; P E Nielsen
Journal:  Nat Biotechnol       Date:  2001-04       Impact factor: 54.908

9.  Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers.

Authors:  B L Geller; J D Deere; D A Stein; A D Kroeker; H M Moulton; P L Iversen
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

10.  The emergence of multidrug resistance to antimicrobial agents for the treatment of typhoid fever.

Authors:  John Wain; Claire Kidgell
Journal:  Trans R Soc Trop Med Hyg       Date:  2004-07       Impact factor: 2.184

View more
  11 in total

1.  Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms.

Authors:  Taketo Otsuka; Aimee L Brauer; Charmaine Kirkham; Erin K Sully; Melinda M Pettigrew; Yong Kong; Bruce L Geller; Timothy F Murphy
Journal:  J Antimicrob Chemother       Date:  2016-09-28       Impact factor: 5.790

2.  Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.

Authors:  David E Greenberg; Kimberly R Marshall-Batty; Lauren R Brinster; Kol A Zarember; Pamela A Shaw; Brett L Mellbye; Patrick L Iversen; Steven M Holland; Bruce L Geller
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 3.  Bacterial antisense RNAs: how many are there, and what are they doing?

Authors:  Maureen Kiley Thomason; Gisela Storz
Journal:  Annu Rev Genet       Date:  2010       Impact factor: 16.830

4.  Targeting essential genes in Salmonella enterica serovar typhimurium with antisense peptide nucleic acid.

Authors:  Muhammad A Soofi; Mohamed N Seleem
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

Review 5.  Use of siRNA molecular beacons to detect and attenuate mycobacterial infection in macrophages.

Authors:  Remo George; Renata Cavalcante; Celso Carvalho; Elyana Marques; Jonathan B Waugh; M Tino Unlap
Journal:  World J Exp Med       Date:  2015-08-20

Review 6.  Targeting the hard to reach: challenges and novel strategies in the treatment of intracellular bacterial infections.

Authors:  Nor Fadhilah Kamaruzzaman; Sharon Kendall; Liam Good
Journal:  Br J Pharmacol       Date:  2016-12-07       Impact factor: 8.739

7.  Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections.

Authors:  Patrick L Iversen; Travis K Warren; Jay B Wells; Nicole L Garza; Dan V Mourich; Lisa S Welch; Rekha G Panchal; Sina Bavari
Journal:  Viruses       Date:  2012-11-06       Impact factor: 5.048

Review 8.  Antisense antimicrobial therapeutics.

Authors:  Erin K Sully; Bruce L Geller
Journal:  Curr Opin Microbiol       Date:  2016-06-29       Impact factor: 7.934

9.  MCR-1 Inhibition with Peptide-Conjugated Phosphorodiamidate Morpholino Oligomers Restores Sensitivity to Polymyxin in Escherichia coli.

Authors:  Seth M Daly; Carolyn R Sturge; Christina F Felder-Scott; Bruce L Geller; David E Greenberg
Journal:  MBio       Date:  2017-11-07       Impact factor: 7.867

10.  Influence of Different Cell-Penetrating Peptides on the Antimicrobial Efficiency of PNAs in Streptococcus pyogenes.

Authors:  Gina Barkowsky; Anna-Lena Lemster; Roberto Pappesch; Anette Jacob; Selina Krüger; Anne Schröder; Bernd Kreikemeyer; Nadja Patenge
Journal:  Mol Ther Nucleic Acids       Date:  2019-09-19       Impact factor: 8.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.